Go Pro
→ Is This the New Normal for Gold? (From Wall Street Logic) (Ad)tc pixel
LON:GENI

GENinCode Final Earnings Report

GENinCode logo
GBX 0.85 0.00 (-0.12%)
As of 05:51 AM Eastern
ProfileEarnings History

GENinCode EPS Results

Actual EPS
-GBX 2.53
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GENinCode Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GENinCode Announcement Details

Quarter
Final
Date
6/4/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GENinCode Earnings Headlines

GENinCode shares rise over 18% intraday after coronary disease test results presented at European conference
August 28, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genincode-shares-rise-over-18-100000784.html
GENinCode PLC
July 30, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/Stock/GENI?countryCode=UK
This Gold Explorer Is Approaching Its Biggest Milestone Yet
A little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.25 g/t. After roughly 21,000 metres of drilling, the company is closing in on its first-ever mineral resource estimate, expected in Q3 or Q4 2026. That estimate could offer the market its first real look at the scale of this emerging gold system.tc pixel
September 16 at 1:00 AM  |  Wall Street Logic (Ad)
GENinCode Shareholders Approve All Resolutions at Annual General Meeting
July 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/genincode-shareholders-approve-all-resolutions-at-annual-general-meeting?utm_source=marketbeat.com&utm_medium=referral
AIM Market Roundup: Marechale Capital, Genincode, Boohoo
June 5, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/aim-market-roundup-marechale-capital-153929945.html
GENinCode slumps after it reprices options
May 7, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genincode-slumps-reprices-options-101000125.html
See More GENinCode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GENinCode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GENinCode and other key companies, straight to your email.

About GENinCode

GENinCode (LON:GENI) is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

View GENinCode Profile
Earnings Tools